0890 100 2 - WURTH ADHESIVE AND SEALING COMPOUND GREY

ChemWatch Material Safety Data Sheet

Issue Date: Fri 10-Oct-2003

CHEMWATCH 7503-08

Section 1 - CHEMICAL PRODUCT AND COMPANY IDENTIFICATION

PRODUCT NAME

0890 100 2 - WURTH ADHESIVE AND SEALING COMPOUND GREY

SYNONYMS

Manufacturer's Code: 0890 100 2 

PRODUCT USE

Used for bonding and sealing work.

SUPPLIER

Company: Wurth Australia Pty Ltd      
Address:                              
4 Redwood Drive (abn 48 002 487 096)  
Dingley                               
VIC, 3175                             
AUSTRALIA                             
Telephone: (+61 3) 9552 9552          
Telephone: 1800 331 603               
Emergency Tel: 1300 657 765           
Fax: 03 9551 2994                     
                                      

Section 2 - HAZARDS IDENTIFICATION

STATEMENT OF HAZARDOUS NATURE

HAZARDOUS SUBSTANCE. NON-DANGEROUS GOODS.

According to the Criteria of NOHSC, and the ADG Code.

POISONS SCHEDULE

None

RISK

May cause SENSITISATION by inhalation.

SAFETY

Avoid exposure - obtain special instructions before use.

Section 3 - COMPOSITION / INFORMATION ON INGREDIENTS

NAME CAS RN %
naphtha petroleum, heavy, hydrodesulfurised 64742-82-1. 1-2.5
xylene 1330-20-7 1-2.5
4,4'-diphenylmethane diisocyanate (MDI) 101-68-8 0.1-0.9

Section 4 - FIRST AID MEASURES

SWALLOWED

· If swallowed do NOT induce vomiting.
· If vomiting occurs, lean patient forward or place on left side (head-down
position, if possible) to maintain open airway and prevent aspiration.
· Observe the patient carefully.
· Never give liquid to a person showing signs of being sleepy or with reduced
awareness; i.e. becoming unconscious.
· Give water to rinse out mouth, then provide liquid slowly and as much as
casualty can comfortably drink.
· Seek medical advice.

EYE

If this product comes in contact with the eyes:
· Wash out immediately with fresh running water.
· Ensure complete irrigation of the eye by keeping eyelids apart and away from
eye and moving the eyelids by occasionally lifting the upper and lower lids.
· If pain persists or recurs seek medical attention.
· Removal of contact lenses after an eye injury should only be undertaken by
skilled personnel.

SKIN

If skin contact occurs:
· Immediately remove all contaminated clothing, including footwear
· Flush skin and hair with running water (and soap if available).
· Seek medical attention in event of irritation.

INHALED

· If fumes or combustion products are inhaled remove from contaminated area.
· Other measures are usually unnecessary.

NOTES TO PHYSICIAN

Treat symptomatically.
For sub-chronic and chronic exposures to isocyanates:
· This material may be a potent pulmonary sensitiser which causes bronchospasm
even in patients without prior airway hyperreactivity.
· Clinical symptoms of exposure involve mucosal irritation of respiratory and
gastrointestinal tracts.
· Conjunctival irritation, skin inflammation (erythema, pain vesiculation) and
gastrointestinal disturbances occur soon after exposure.
· Pulmonary symptoms include cough, burning, substernal pain and dyspnoea.
· Some cross-sensitivity occurs between different isocyanates.
· Noncardiogenic pulmonary edema and bronchospasm are the most serious
consequences of exposure. Markedly symptomatic patients should receive oxygen,
ventilatory support and an intravenous line.
· Treatment for asthma includes inhaled sympathomimetics (epinephrine
[adrenalin], terbutaline) and steroids.
· Activated charcoal (1 g/kg) and a cathartic (sorbitol, magnesium citrate) may
be useful for ingestion.
· Mydriatics, systemic analgesics and topical antibiotics (Sulamyd) may be used
for corneal abrasions.
· There is no effective therapy for sensitised workers.
[Ellenhorn and Barceloux; Medical Toxicology]
NOTE: Isocyanates cause airway restriction in naive individuals with the degree
of response dependant on the concentration and duration of exposure. They induce
smooth muscle contraction which leads to bronchoconstrictive episodes. Acute
changes in lung function, such as decreased FEV1, may not represent sensitivity.
[Karol & Jin, Frontiers in Molecular Toxicology, pp 56-61, 1992]

Section 5 - FIRE FIGHTING MEASURES

EXTINGUISHING MEDIA

· Foam.
· Dry chemical powder.
· BCF (where regulations permit).
· Carbon dioxide.
· Water spray or fog - Large fires only.

FIRE FIGHTING

· Alert Fire Brigade and tell them location and nature of hazard.
· Wear breathing apparatus plus protective gloves.
· Prevent, by any means available, spillage from entering drains or water
courses.
· Use water delivered as a fine spray to control fire and cool adjacent area.
· DO NOT approach containers suspected to be hot.
· Cool fire exposed containers with water spray from a protected location.
· If safe to do so, remove containers from path of fire.
· Equipment should be thoroughly decontaminated after use.

FIRE/EXPLOSION HAZARD

· Combustible.
· Slight fire hazard when exposed to heat or flame.
· Heating may cause expansion or decomposition leading to violent rupture of
containers.
· On combustion, may emit toxic fumes of carbon monoxide (CO).
· May emit acrid smoke.
· Mists containing combustible materials may be explosive.
Combustion products include , carbon dioxide (CO2) , isocyanates , and minor
amounts of , hydrogen cyanide , hydrogen chloride , phosgene , nitrogen oxides
(NOx) , other pyrolysis products typical of burning organic material

FIRE INCOMPATIBILITY

Avoid contamination with oxidising agents i.e. nitrates, oxidising acids,
chlorine bleaches, pool chlorine etc. as ignition may result

HAZCHEM

None

Personal Protective Equipment

PERSONAL PROTECTION EQUIPMENT
Gas tight chemical resistant suit.
Limit exposure duration to 1 BA set - 30 mins.

Section 6 - ACCIDENTAL RELEASE MEASURES

EMERGENCY PROCEDURES

MINOR SPILLS

· Clean up all spills immediately.
· Avoid contact with skin and eyes.
· Wear impervious gloves and safety goggles.
· Trowel up/scrape up.
· Place spilled material in clean, dry, sealed container.
· Flush spill area with water.

MAJOR SPILLS

Minor hazard.
· Clear area of personnel.
· Alert Fire Brigade and tell them location and nature of hazard.
· Control personal contact by using protective equipment as required.
· Prevent spillage from entering drains or water ways.
· Contain spill with sand, earth or vermiculite.
· Collect recoverable product into labelled containers for recycling.
· Absorb remaining product with sand, earth or vermiculite and place in
appropriate containers for disposal.
· Wash area and prevent runoff into drains or waterways.
· If contamination of drains or waterways occurs, advise emergency services.

 

Personal Protective Equipment advice is contained in Section 8 of the MSDS.

Section 7 - HANDLING AND STORAGE

PROCEDURE FOR HANDLING

· Avoid all personal contact, including inhalation.
· Wear protective clothing when risk of exposure occurs.
· Use in a well-ventilated area.
· Prevent concentration in hollows and sumps.
· DO NOT enter confined spaces until atmosphere has been checked.
· DO NOT allow material to contact humans, exposed food or food utensils.
· Avoid contact with incompatible materials.
· When handling, DO NOT eat, drink or smoke.
· Keep containers securely sealed when not in use.
· Avoid physical damage to containers.
· Always wash hands with soap and water after handling.
· Work clothes should be laundered separately. Launder contaminated clothing
before re-use.
· Use good occupational work practice.
· Observe manufacturer's storing and handling recommendations.
· Atmosphere should be regularly checked against established exposure standards
to ensure safe working conditions are maintained.

SUITABLE CONTAINER

· Metal can or drum
· Packaging as recommended by manufacturer.
· Check all containers are clearly labelled and free from leaks.

STORAGE INCOMPATIBILITY

Avoid reaction with oxidising agents

STORAGE REQUIREMENTS

· Store in original containers.
· Keep containers securely sealed.
· Store in a cool, dry, well-ventilated area.
· Store away from incompatible materials and foodstuff containers.
· Protect containers against physical damage and check regularly for leaks.
· Observe manufacturer's storing and handling recommendations.

Section 8 - EXPOSURE CONTROLS / PERSONAL PROTECTION

EXPOSURE CONTROLS

No data available for naphtha petroleum, heavy, hydrodesulfurised as (CAS: 64742-82-1) /
  (CAS: 8052-41-3) / (CAS: 1330-20-7) / (CAS: 101-68-8) / (CAS: 26447-40-5 *)
Not available. Refer to individual constituents.

EXPOSURE STANDARDS FOR MIXTURE

    "Worst Case" computer-aided prediction of vapour components/concentrations:
     
    Composite Exposure Standard for Mixture (TWA) (mg/m³): 0.3341 mg/m³
    If the breathing zone concentration of ANY of the components listed below is
    exceeded, "Worst Case" considerations deem the individual to be overexposed.
    Component Breathing Zone ppm Breathing Zone mg/m³ Mixture Conc: (%)
    
    Component                           Breathing zone  Breathing Zone  Mixture Conc
                                        (ppm)           (mg/m³)         (%)
    4,4'-diphenylmethane diisocyanate   0.00            0.0510          0.9
    xylene                              0.03            0.1416          2.5
    naphtha petroleum, heavy, hydrodes  0.03            0.1416          2.5

INGREDIENT DATA

NAPHTHA PETROLEUM, HEAVY, HYDRODESULFURISED:
   PEL TWA:  500 ppm, 2900 mg/m³ [OSHA Z1]
   ES TWA: 790 mg/m³ (as white spirit)
   TLV TWA: 100 ppm, 525 mg/m³ (as Stoddard Solvent)

XYLENE:
   TLV TWA: 100 ppm A4;BEI [ACGIH]
   TLV STEL: 150 ppm A4;BEI [ACGIH]
   PEL TWA:  100 ppm, 435 mg/m³ [OSHA Z1]
   TLV TWA: 100 ppm, 434 mg/m³; STEL: 150 ppm, 651 mg/m³  A4
   NOTE: This substance has been classified by the ACGIH as A4 NOT classifiable as
   causing Cancer in humans
   ES TWA: 80 ppm, 350 mg/m³; STEL: 150 ppm, 655 mg/m³ (Under review)
   OES TWA: 100 ppm, 441 mg/m³; STEL: 150 ppm, 662 mg/m³  skin
   Exposure limits with "skin" notation indicate that vapour and liquid may be
   absorbed through intact skin. Absorption by skin may readily exceed vapour
   inhalation exposure. Symptoms for skin absorption are the same as for
   inhalation. Contact with eyes and mucous membranes may also contribute to
   overall exposure and may also invalidate the exposure standard.
   IDLH Level: 900 ppm
   Odour Threshold Value: 20 ppm (detection), 40 ppm (recognition)
   NOTE: Detector tubes for o-xylene, measuring in excess of 10 ppm, are
         available commercially. (m-xylene and p-xylene give almost the same
         response)

   Xylene vapour is an irritant to the eyes, mucous membranes and skin and
   causes narcosis at high concentrations. Exposure to doses sufficiently high
   to produce intoxication and unconsciousness also produces transient liver
   and kidney toxicity. Neurologic impairment is NOT evident amongst
   volunteers inhaling up to 400 ppm though complaints of ocular and upper
   respiratory tract irritation occur at 200 ppm for 3 to 5 minutes.
   Exposure to xylene at or below the recommended TLV-TWA and STEL is thought
   to minimise the risk of irritant effects and to produce neither significant
   narcosis or chronic injury. An earlier skin notation was deleted because
   percutaneous absorption is gradual and protracted and does not
   substantially contribute to the dose received by inhalation.

4,4'-DIPHENYLMETHANE DIISOCYANATE (MDI):
   TLV TWA: 0.02 ppm [ACGIH]
   TLV TWA: 0.005 ppm [ACGIH]
   PEL Ceiling:  0.02 ppm,  0.2 mg/m³ [OSHA Z1] [OSHA Z1]
   isocyanates, all as NCO (Mol.Wt: 42.00)
   ES TWA: 0.02 mg/m³; STEL: 0.07 mg/m³ sensitiser
   MEL TWA: 0.02 mg/m³; STEL: 0.07 mg/m³ sensitiser
   Some jurisdictions require that health surveillance be conducted on
   occupationally exposed workers. This should emphasise:
   · demography, occupational and medical history and health advice
   · completion of a standardised respiratory questionnaire
   · physical examination of the respiratory system and skin
   · standardised respiratory function tests such as FEV1, FVC and FEV1/FVC
     diphenyl methane diisocyanate as methylene bisphenyl isocyanate MDI
   TLV TWA: 0.005 ppm; 0.051 mg/m³  as -NCO                   [ACGIH]
   MAK value: 0.05 mg/m³
   Designated S in List of MAK values: Danger of sensitization.
   MAK Category I Peak Limitation: For local irritants Allows excursions of twice
   the MAK value for 5 minutes at a time, 8 times per shift.
   MAK IIIB: Substances suspected of having carcinogenic potential.
   MAK Group IIc: Substances with MAK Values but no pregnancy risk group
   classification. These are substances which have been investigated but for which
   no information regarding possible damage to the foetus/embryo was found. Mention
   calls attention to the absence of adequate data.
   MAK values, and categories and groups are those recommended within the
   Federal Republic of Germany
   REL TWA:  0.005 ppm, REL C 0.02 ppm/10 min       [NIOSH 1985]
   Odour Threshold Value: 0.39 ppm
   IDLH Level: 75 mg/m³
      Mean MDI exposures of less than 0.003 ppm appear to have no acute or
   chronic effect on pulmonary function.
   MDI produces identical toxicological responses to those produced by TDI
   and the recommended TLV-TWA is identical for the two isocyanates. Exposure
   at or below the recommended value is thought to protect the worker against
   pulmonary function decrements as well as to minimise the potential for
   respiratory tract sensitisation. Individuals who may be hypersusceptible
   or otherwise unusually responsive to exposure to certain industrial
   chemicals may not adequately protected from adverse health effects caused
   by MDI at the recommended TLV-TWA. Ceiling values recommended by NIOSH
   and OSHA are synonymous with normal excursions allowable for exposures to
   the TLV-TWA (in excess of 3 x TLV-TWA for no more than a total of
   30 minutes during a work day but in any case not exceeding 5 x TLV-TWA).

PERSONAL PROTECTION

EYE

· Safety glasses with side shields
· Chemical goggles.
· Contact lenses pose a special hazard; soft lenses may absorb irritants and all
lenses concentrate them.

HANDS/FEET

Wear chemical protective gloves, eg. PVC.
Wear safety footwear or safety gumboots, eg. Rubber

OTHER

· Overalls.
· P.V.C. apron.
· Barrier cream.
· Skin cleansing cream.
· Eye wash unit.

RESPIRATOR

Respiratory protection is required when ANY "Worst Case" vapour-phase
concentration is exceeded (see Computer Prediction in "Exposure Standards").

Protection Factor (Min)  Half-Face Respirator  Full-Face Respirator
10 x ES                  A-AUS                 -
                         A-PAPR-AUS            -
50 x ES                  -                     A-AUS
                         -                     A-PAPR-AUS
100 x ES                 -                     A-2
                         -                     A-PAPR-2


^ - Full-face

The local concentration of material, quantity and conditions of use determine
the type of personal protective equipment required. For further information
consult site specific CHEMWATCH data (if available), or your Occupational
Health and Safety Advisor.

ENGINEERING CONTROLS

Local exhaust ventilation usually required. If risk of overexposure exists, wear
approved respirator. Correct fit is essential to obtain adequate protection.
Supplied-air type respirator may be required in special circumstances. Correct
fit is essential to ensure adequate protection.
An approved self contained breathing apparatus (SCBA) may be required in some
situations.
Provide adequate ventilation in warehouse or closed storage area. 

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

APPEARANCE

Grey paste with a characteristic odour; reacts with water.

PHYSICAL PROPERTIES

 

Molecular Weight: Not Applicable                Boiling Range (ºC): Not Available
Melting Range (ºC): Not Available               Specific Gravity (water=1): 1.26 approx.
Solubility in water (g/L): Reacts               pH (as supplied): Not Applicable
pH (1% solution): Not Applicable                Vapour Pressure (kPa): Not Available
Volatile Component (%vol): 4.05 approx.         Evaporation Rate: Not Available
Relative Vapour Density (air=1): Not Available  Flash Point (ºC): >65
Lower Explosive Limit (%): Not Available        Upper Explosive Limit (%): Not Available
Autoignition Temp (ºC): Not Available           Decomposition Temp (ºC): Not Available
State: Non Slump Paste

Section 10 - CHEMICAL STABILITY AND REACTIVITY INFORMATION

CONDITIONS CONTRIBUTING TO INSTABILITY

Product is considered stable and hazardous polymerisation will not occur.

Section 11 - TOXICOLOGICAL INFORMATION

POTENTIAL HEALTH EFFECTS

ACUTE HEALTH EFFECTS

SWALLOWED

The material has NOT been classified by EC Directives or other classification
systems as "harmful by ingestion". This is because of the lack of corroborating
animal or human evidence. The material may still be damaging to the health of
the individual, following ingestion, especially where pre-existing organ (e.g
liver, kidney) damage is evident. Present definitions of harmful or toxic
substances are generally based on doses producing mortality rather than those
producing morbidity (disease, ill-health). Gastrointestinal tract discomfort may
produce nausea and vomiting. In an occupational setting however, ingestion of
insignificant quantities is not thought to be cause for concern.

EYE

Although the material is not thought to be an irritant (as classified by EC
Directives), direct contact with the eye may produce transient discomfort
characterised by tearing or conjunctival redness (as with windburn).

SKIN

The material is not thought to produce adverse health effects or skin irritation
following contact (as classified by EC Directives using animal models).
Nevertheless, good hygiene practice requires that exposure be kept to a minimum
and that suitable gloves be used in an occupational setting.
Entry into the blood-stream, through, for example, cuts, abrasions or lesions,
may produce systemic injury with harmful effects. Examine the skin prior to the
use of the material and ensure that any external damage is suitably protected.

INHALED

The material is not thought to produce adverse health effects or irritation of
the respiratory tract (as classified by EC Directives using animal models).
Nevertheless, good hygiene practice requires that exposure be kept to a minimum
and that suitable control measures be used in an occupational setting.

CHRONIC HEALTH EFFECTS

Practical evidence shows that inhalation of the material is capable of inducing a
sensitisation reaction in a substantial number of individuals at a greater frequency than
would be expected from the response of a normal population. Pulmonary sensitisation,
resulting in hyperactive airway dysfunction and pulmonary allergy may be accompanied by
fatigue, malaise and aching. Significant symptoms of exposure may persist for extended
periods, even after exposure ceases. Symptoms can be activated by a variety of nonspecific
environmental stimuli such as automobile exhaust, perfumes and passive smoking.
Sensitisation may give severe responses to very low levels of exposure, in situations
where exposure may occur. Prolonged or repeated skin contact may cause drying with
cracking, irritation and possible dermatitis following. Chronic solvent inhalation
exposures may result in nervous system impairment and liver and blood changes. [PATTYS].
As with any chemical product, contact with unprotected bare skin; inhalation of vapour,
mist or dust in work place atmosphere; or ingestion in any form, should be avoided by
observing good occupational work practice.

0890 100 2 - Wurth Adhesive And Sealing Compound Grey

None assigned. Refer to individual constituents.
unless otherwise specified data extracted from RTECS - Register of Toxic Effects
of Chemical Substances

NAPHTHA PETROLEUM, HEAVY, HYDRODESULFURISED:
No data of toxicological significance identified in literature search.

XYLENE:
TOXICITY                             IRRITATION
Oral (human) LDLo: 50 mg/kg          Skin (rabbit):500 mg/24h moderate
Oral (rat) LD50: 4300 mg/kg          Eye (human): 200 ppm irritant
Inhalation (human) TCLo: 200 ppm     Eye (rabbit): 87 mg mild
Inhalation (man) LCLo: 10000 ppm/6h  Eye (rabbit): 5 mg/24h SEVERE
Inhalation (rat) LC50: 5000 ppm/4h
Reproductive effector in rats
The substance is classified by IARC as Group 3:
NOT classifiable as to its carcinogenicity to humans.
Evidence of carcinogenicity may be inadequate or limited in animal testing.

4,4'-DIPHENYLMETHANE DIISOCYANATE (MDI):
TOXICITY                                IRRITATION
Oral (rat) LDLo: 9200 mg/kg             Skin (rabbit): 500 mg /24 hours
Inhalation(human)TCLo:0.13 ppm/30 mins  Eye (rabbit): 0.10 mg moderate
Inhalation (rat) LC50: 178 mg/m3/4h
Oral (mouse) LD50: 2200 mg/kg
Dermal (rabbit) LD50: > 6200 mg/kg *    Dermal Sensitiser *
                                          Respiratory Sensitiser (g.pig) *
                                           [* = Bayer CCINFO 2133615]
The substance is classified by IARC as Group 3:
NOT classifiable as to its carcinogenicity to humans.
Evidence of carcinogenicity may be inadequate or limited in animal testing.

Section 12 - ECOLOGICAL INFORMATION

Drinking Water Standards:
hydrocarbon total: 10 ug/l (UK max.).
DO NOT discharge into sewer or waterways.
Water Hazard Class 1: slightly hazardous to water. [Wurth]

Section 13 - DISPOSAL CONSIDERATIONS

· Recycle wherever possible or consult manufacturer for recycling options.
· Consult State Land Waste Management Authority for disposal.
· Bury residue in an authorised landfill.
· Recycle containers if possible, or dispose of in an authorised landfill.

Section 14 - TRANSPORTATION INFORMATION

Shipping Name:
None

Dangerous Goods Class: None
UN/NA Number: None
ADR Number: None
Packing Group: None
Labels Required:
Additional Shipping Information:
International Transport Regulations:
IMO: None

HAZCHEM

None

Section 15 - REGULATORY INFORMATION

POISONS SCHEDULE

None

Section 16 - OTHER INFORMATION

 

This document is copyright. Apart from any fair dealing for the purposes of
private study, research, review or criticism, as permitted under the Copyright
Act, no part may be reproduced by any process without written permission from
CHEMWATCH. TEL (+61 3) 9572 4700.

 

Issue Date: Fri 10-Oct-2003

Print Date: Wed 9-Feb-2005